Results posted for phase 1 trial of Autologous T-regulatory lymphocytes
Original source
Phase 1 trial of Autologous T-regulatory lymphocytes completes (opens in a new tab)1 further copy of this report was also considered.
Trial at a glance
- Status
- Completed
- Phase
- Phase 1
- Intervention
- Autologous T-regulatory lymphocytes (biological)
- Enrolment
- 3 participants (actual)
- Site
- the United States
- Sponsor
- The Methodist Hospital Research Institute
- Registration
- NCT03241784
Compass reports what the trial registry states. A trial being registered, recruiting or completed is not evidence that a treatment works.
This completed Phase 1 interventional study tested autologous T-regulatory lymphocytes and interleukin-2 in 3 people with amyotrophic lateral sclerosis at sites in the United States. Results have been posted, which is the latest change to the registry record.
Why this matters
The study is completed and results have been posted, so this research record now includes results information for people tracking ALS/MND research. The registry fields do not provide details of those results.
Trial updates
Results posted — 17 June 2026
- 17 June 2026Study completed
Compass began tracking this trial’s registry record on the date of its first update above. Changes before then are not listed.